Biosortia Microbiomics

About:

Biosortia works on new drugs from deep access to the chemistry of the microbiome for immuno-oncology and immunological therapeutics.

Website: http://www.biosortia.com/

Twitter/X: Biosortia

Top Investors: Keiretsu Forum

Description:

Biosortia Microbiomics has unique access to the hidden chemistry of the microbiome. The only capability in the world to obtain the long-sought, but previously unobtainable drug-like molecules directly from the microbiome leading to direct access of hidden molecules and filling the key missing data for artificial intelligence (AI).

Total Funding Amount:

$22M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Dublin, Ohio, United States

Founded Date:

2012-01-01

Contact Email:

Inquiries(AT)Biosortia.com

Founders:

Ross Youngs

Number of Employees:

11-50

Last Funding Date:

2017-10-01

IPO Status:

Private

© 2024 MyAiNote.com